Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
David Williams, MD
Researcher Senior Vice President
Division of Hematology
Boston Children's Hospital
300 Longwood Avenue
Boston, Massachusetts, United States
Dr. Williams is the president of Dana-Farber Cancer and Blood Disorders Center. He also serves as Senior Vice President and Chief Scientific Officer at Boston Children’s Hospital and the Chief of Hematology/Oncology at Boston Children’s Hospital. He is also working as Leland Fikes Professor of Pediatrics at Harvard Medical School. His major research interests are – study of blood stem cell biology, blood formation, leukemia and the treatment of genetic blood diseases using gene therapy. Dr. Williams is originally trained in hematology/oncology at Boston Children’s Hospital and Dana-Farber Cancer Institute. During his fellowship research at the MIT Cancer Center and the Whitehead Institute, he developed techniques that allowed for the introduction of genes into murine and human hematopoietic cells. Those techniques are still commonly utilized today. He has published over 250 peer-reviewed manuscripts and textbook chapters.
Representative Publications:
Sickle cell disease pain: II. Predicting health care use and activity level at 9-month follow-up
Pain drawings and sickle cell disease pain
Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype
+myBinderRelated Content
-
Wanda Whitten-Shurney, MDDr. Wanda Whitten-Shurney is a pediatric...
-
Practice variation in emergency department management of children with sickle cell disease who present with feverOBJECTIVES:Urgent medical evaluation is ...
-
St. Louis Children’s HospitalThe St. Louis Children's Hospital Sickle...
-
Patrick Woster, PhDPatrick M. Woster is professor of drug d...
-
Coronavirus Preparedness for People With Chronic Diseaseshttps://www.youtube.com/watch?v=G_JC3vUT...
-
Guy’s and St Thomas’ NHS Foundation TrustOur haemoglobinopathies service sees chi...
-
Pediatric prescriber pratices of hyrdoxyurea in sickle cell diseaseHydroxyurea (HU) has been shown to be ef...
